14 results
DEFA14A
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
Additional proxy soliciting materials
9:14am
availability of raw materials. Even if we obtain marketing approval for ABP-450, there is no assurance that Daewoong will be able to manufacture
DEFM14A
40cltczwh dufg1mx
12 May 23
Proxy related to merger
5:00pm
424B3
60o e71rbtr19w6sc32
12 May 23
Prospectus supplement
4:33pm
S-4
spyfulv4sxyy3s
23 Dec 22
Registration of securities issued in business combination transactions
6:28pm
- Prev
- 1
- Next